Winning and Losing Stocks in the Healthcare Sector for the Week Ending Dec 9th

Wall St. Watchdog reveals information about winning and losing stocks in the Healthcare (NYSE:XLV) sector for the week ending Dec 9th, 2011:

Gainers (% price change)

  • Athersys, Inc. (NASDAQ:ATHX): The shares closed at $2.03, up $0.73, or 56.06%, on the week. Its market capitalization is $48.41 million. About the company: Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes. Get the most recent company news and stock data here >>
  • Affymax, Inc. (NASDAQ:AFFY): The shares closed at $7.64, up $2.73, or 55.56%, on the week. Its market capitalization is $285.13 million. About the company: Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer. Get the most recent company news and stock data here >>
  • Response Genetics, Inc (NASDAQ:RGDX): The shares closed at $1.41, up $0.38, or 37%, on the week. Its market capitalization is $26.77 million. About the company: Response Genetics, Inc. is a biopharmaceutical company that researches and develops pharmacogenomic diagnostic tests. The Company’s products are targeted for potential use in the treatment of cancer. Get the most recent company news and stock data here >>
  • Cyanotech Corp. (NASDAQ:CYAN): The shares closed at $8.59, up $2, or 30.38%, on the week. Its market capitalization is $41.33 million. About the company: Cyanotech Corporation produces natural products from microalgae. The Company provides NatuRose natural astaxanthin used in the worldwide agriculture and animal feed industry. Cynotech also provides Sirulina Pacifica, a nutrient-rich dietary supplement, and phycobiliproteins, which are florescent pigments used in the immunological diagnostics market. Get the most recent company news and stock data here >>
  • Adeona Pharmaceuticals, Inc. (AMEX:AEN): The shares closed at $1.42, up $0.32, or 28.57%, on the week. Its market capitalization is $35.54 million. About the company: Adeona Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on the development and commercialization of drug candidates for the treatment of neurologic and fibrotic diseases. Get the most recent company news and stock data here >>

Losers (% price change)

  • Alexza Pharmaceuticals Inc. (NASDAQ:ALXA): The shares closed at $0.63, down $0.57, or 47.47%, on the week. Its market capitalization is $37.51 million. About the company: Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions. Get the most recent company news and stock data here >>
  • Graymark Healthcare, Inc. (NASDAQ:GRMH): The shares closed at $0.50, down $0.21, or 29.41%, on the week. Its market capitalization is $9.04 million. About the company: Graymark Healthcare, Inc. is a diversified holding company within the medical industry. The Company owns and operates independent pharmacies, diagnostic sleep centers, and medical equipment companies. Get the most recent company news and stock data here >>
  • Invacare Corporation (NYSE:IVC): The shares closed at $16.00, down $6.27, or 28.15%, on the week. Its market capitalization is $484.51 million. About the company: Invacare Corporation manufactures and distributes health care products to the non-acute care market on a worldwide basis. The Company distributes its products to home care, mass retail, and institutional customers. Invacare provides items such as respiratory products, home care beds, diabetic supplies, nursing home furniture, and manual and powerized wheelchairs. Get the most recent company news and stock data here >>
  • Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): The shares closed at $1.06, down $0.29, or 21.48%, on the week. Its market capitalization is $29.29 million. About the company: Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases. Get the most recent company news and stock data here >>
  • Complete Genomics, Inc. (NASDAQ:GNOM): The shares closed at $3.00, down $0.71, or 19.23%, on the week. Its market capitalization is $97.55 million. About the company: Complete Genomics Inc. is a biomedical company. The Company discovers genome sequencing of human populations using DNA that allows large-scale human genome studies. Get the most recent company news and stock data here >>

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet